Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer()

The MIS pathway is a potential therapeutic target in epithelial ovarian cancer (EOC): signaling requires both type II (T2R) and type I receptors (T1R), and results in growth inhibition. MISR2 is expressed in EOC, but the prevalence and relative contributions of candidate T1R remain unknown. We sough...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Mol Med
Autors principals: Basal, E., Ayeni, T., Zhang, Q., Langstraat, C., Donahoe, P.K., Pepin, D., Yin, X., Leof, E., Cliby, W.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4813308/
https://ncbi.nlm.nih.gov/pubmed/26917267
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars